Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats

Neurobiology of Disease

Volumn 59, Issue , 2013, Pages 230-243

  Rumpel, Regina ^a   Alam, Mesbah ^a   Klein, Alexander ^a   Özer, Meltem ^a   Wesemann, Maike ^a   Jin, Xingxing ^a   Krauss, Joachim K ^a   Schwabe, Kerstin ^a   Ratzka, Andreas ^a   Grothe, Claudia ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

6 OHDA; Beta oscillatory activity; Brain repair; Drug induced rotation; Electrophysiology; Embryonic tissue; Extracellular recordings; Firing rate; RT PCR; Transplantation

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; AMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXIDOPAMINE; PROTEIN AMPA3; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA RHYTHM; CIRCLING BEHAVIOR; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYO; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; MESENCEPHALON; NERVE CELL STIMULATION; NERVE TRANSPLANTATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SUBTHALAMIC NUCLEUS;

6-OHDA; BETA-OSCILLATORY ACTIVITY; BRAIN REPAIR; DRUG-INDUCED ROTATION; ELECTROPHYSIOLOGY; EMBRYONIC TISSUE; EXTRACELLULAR RECORDINGS; FIRING RATE; RT-PCR; TRANSPLANTATION;

ACTION POTENTIALS; ADRENERGIC AGENTS; ANIMALS; CELLS, CULTURED; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FEMALE; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; MESENCEPHALON; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; SUBTHALAMIC NUCLEUS; TYROSINE 3-MONOOXYGENASE;

EID: 84883345653     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.07.016     Document Type: Article

References (74)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 1946, 94:239-247.
2. Alam M., Heissler H.E., Schwabe K., Krauss J.K. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model. Exp. Neurol. 2012, 233:233-242.
3. Alonso-Frech F., Zamarbide I., Alegre M., Rodriguez-Oroz M.C., Guridi J., Manrique M., Valencia M., Artieda J., Obeso J.A. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain 2006, 129:1748-1757.
4. Aristieta A., Azkona G., Sagarduy A., Miguelez C., Ruiz-Ortega J.A., Sanchez-Pernaute R., Ugedo L. The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats. PLoS One 2012, 7:e42652.
5. Björklund A., Stenevi U., Schmidt R.H., Dunnett S.B., Gage F.H. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. Suppl. 1983, 522:1-7.
6. Breit S., Bouali-Benazzouz R., Popa R.C., Gasser T., Benabid A.L., Benazzouz A. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp. Neurol. 2007, 205:36-47.
7. Brundin P., Barker R.A., Parmar M. Neural grafting in Parkinson's disease problems and possibilities. Prog. Brain Res. 2010, 184:265-294.
8. Cenci M.A., Lindgren H.S. Advances in understanding L-DOPA-induced dyskinesia. Curr. Opin. Neurobiol. 2007, 17:665-671.
9. Centonze D., Gubellini P., Usiello A., Rossi S., Tscherter A., Bracci E., Erbs E., Tognazzi N., Bernardi G., Pisani A., Calabresi P., Borrelli E. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. Neuroscience 2004, 129:157-166.
10. Chritin M., Savasta M., Mennicken F., Bal A., Abrous D.N., Le Moal M., Feuerstein C., Herman J.P. Intrastriatal dopamine-rich implants reverse the increase of dopamine D2 receptor mRNA levels caused by lesion of the nigrostriatal pathway: a quantitative in situ hybridization study. Eur. J. Neurosci. 1992, 4:663-672.
11. Coune P., Craveiro M., Gaugler M., Mlynárik V., Schneider B., Aebischer P., Gruetter R. An in vivo ultrahigh field 14.1T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker. NMR Biomed. 2013, 26:43-50.
12. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 2006, 9:251-259.
13. Deumens R., Blokland A., Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 2002, 175:303-317.
14. Dunah A.W., Wang Y., Yasuda R.P., Kameyama K., Huganir R.L., Wolfe B.B., Standaert D.G. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol. 2000, 57:342-352.
15. Dunnett S.B., Rosser A.E. Clinical translation of cell transplantation in the brain. Curr. Opin. Organ Transplant 2011, 16:632-639.
16. Dunnett S.B., Hernandez T.D., Summerfield A., Jones G.H., Arbuthnott G. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 1988, 71:411-424.
17. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
18. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250:1429-1432.
19. Gilmour T.P., Piallat B., Lieu C.A., Venkiteswaran K., Ramachandra R., Rao A.N., Petticoffer A.C., Berk M.A., Subramanian T. The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats. Brain 2011, 134:3276-3289.
20. Gittis A.H., Hang G.B., LaDow E.S., Shoenfeld L.R., Atallah B.V., Finkbeiner S., Kreitzer A.C. Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. Neuron 2011, 71:858-868.
21. Halliday D.M., Rosenberg J.R., Amjad A.M., Breeze P., Conway B.A., Farmer S.F. A framework for the analysis of mixed time series/point process data-theory and application to the study of physiological tremor, single motor unit discharges and electromyograms. Prog. Biophys. Mol. Biol. 1995, 64:237-278.
22. Hammond C., Bergman H., Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci. 2007, 30:357-364.
23. Hashimoto T., Elder C.M., Okun M.S., Patrick S.K., Vitek J.L. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J. Neurosci. 2003, 23:1916-1923.
24. Hickey P., Stacy M. Available and emerging treatments for Parkinson's disease: a review. Drug Des. Devel Ther. 2011, 5:241-254.
25. Hommel J.D., Sears R.M., Georgescu D., Simmons D.L., DiLeone R.J. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 2003, 9:1539-1544.
26. Hutchison W.D., Dostrovsky J.O., Walters J.R., Courtemanche R., Boraud T., Goldberg J., Brown P. Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. J. Neurosci. 2004, 24:9240-9243.
27. Johnston T., Duty S. Changes in GABA(B) receptor mRNA expression in the rodent basal ganglia and thalamus following lesion of the nigrostriatal pathway. Neuroscience 2003, 120:1027-1035.
28. Jungnickel J., Kalve I., Reimers L., Nobre A., Wesemann M., Ratzka A., Halfer N., Lindemann C., Schwabe K., Töllner K., Gernert M., Grothe C. Topology of intrastriatal dopaminergic grafts determines functional and emotional outcome in neurotoxin-lesioned rats. Behav. Brain Res. 2011, 216:129-135.
29. Kaneoke Y., Vitek J.L. Burst and oscillation as disparate neuronal properties. J. Neurosci. Methods 1996, 68:211-223.
30. Khan Z.U., Mrzljak L., Gutierrez A., De la Calle A., Goldman-Rakic P.S. Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7731-7736.
31. Klein A., Metz G.A., Papazoglou A., Nikkhah G. Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats. Neurobiol. Dis. 2007, 27:24-35.
32. Kreiss D.S., Mastropietro C.W., Rawji S.S., Walters J.R. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J. Neurosci. 1997, 17:6807-6819.
33. Kühn A.A., Kempf F., Brucke C., Gaynor Doyle L., Martinez-Torres I., Pogosyan A., Trottenberg T., Kupsch A., Schneider G.H., Hariz M.I., Vandenberghe W., Nuttin B., Brown P. High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J. Neurosci. 2008, 28:6165-6173.
34. Labarre D., Meissner W., Boraud T. Measure of the regularity of events in stochastic point processes, application to neuron activity analysis. 33rd IEEE Proceedings, International Conference on Acoustics, Speech and Signal Processing 2008.
35. Lafreniere-Roula M., Darbin O., Hutchison W.D., Wichmann T., Lozano A.M., Dostrovsky J.O. Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients. Exp. Neurol. 2010, 225:455-458.
36. Lehmkuhle M.J., Bhangoo S.S., Kipke D.R. The electrocorticogram signal can be modulated with deep brain stimulation of the subthalamic nucleus in the hemiparkinsonian rat. J. Neurophysiol. 2009, 102:1811-1820.
37. Levy R., Dostrovsky J.O., Lang A.E., Sime E., Hutchison W.D., Lozano A.M. Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. J. Neurophysiol. 2001, 86:249-260.
38. Levy R., Ashby P., Hutchison W.D., Lang A.E., Lozano A.M., Dostrovsky J.O. Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain 2002, 125:1196-1209.
39. Litvak V., Jha A., Eusebio A., Oostenveld R., Foltynie T., Limousin P., Zrinzo L., Hariz M.I., Friston K., Brown P. Resting oscillatory cortico-subthalamic connectivity in patients with Parkinson's disease. Brain 2011, 134:359-374.
40. Logothetis N.K. The underpinnings of the BOLD functional magnetic resonance imaging signal. J. Neurosci. 2003, 23:3963-3971.
41. Mallet N., Pogosyan A., Márton L.F., Bolam J.P., Brown P., Magill P.J. Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity. J. Neurosci. 2008, 28:14245-14258.
42. Mallet N., Pogosyan A., Sharott A., Csicsvari J., Bolam J.P., Brown P., Magill P.J. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J. Neurosci. 2008, 28:4795-4806.
43. Mathai A., Smith Y. The corticostriatal and corticosubthalamic pathways: two entries, one target. So what?. Front. Syst. Neurosci. 2011, 5:64.
44. Medhurst A.D., Harrison D.C., Read S.J., Campbell C.A., Robbins M.J., Pangalos M.N. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods 2000, 98:9-20.
45. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., Björklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 1994, 63:57-72.
46. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
47. Parr-Brownlie L.C., Poloskey S.L., Flanagan K.K., Eisenhofer G., Bergstrom D.A., Walters J.R. Dopamine lesion-induced changes in subthalamic nucleus activity are not associated with alterations in firing rate or pattern in layer V neurons of the anterior cingulate cortex in anesthetized rats. Eur. J. Neurosci. 2007, 26:1925-1939.
48. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2006, Academic Press, San Diego. 6th Edn.
49. Pincus S. Approximate entropy (ApEn) as a complexity measure. Chaos 1995, 5:110-117.
50. Puschban Z., Scherfler C., Granata R., Laboyrie P., Quinn N.P., Jenner P., Poewe W., Wenning G.K. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc. Neuroscience 2000, 95:377-388.
51. Rasch M.J., Gretton A., Murayama Y., Maass W., Logothetis N.K. Inferring spike trains from local field potentials. J. Neurophysiol. 2008, 99:1461-1476.
52. Ratzka A., Baron O., Grothe C. FGF-2 deficiency does not influence FGF ligand and receptor expression during development of the nigrostriatal system. PLoS One 2011, 6:e23564.
53. Ratzka A., Kalve I., Ozer M., Nobre A., Wesemann M., Jungnickel J., Koster-Patzlaff C., Baron O., Grothe C. The co-layer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease. Cell Transplant. 2012, 21:749-762.
54. Remple M.S., Bradenham C.H., Kao C.C., Charles P.D., Neimat J.S., Konrad P.E. Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression. Mov. Disord. 2011, 26:1657-1662.
55. Richardson R.M., Freed C.R., Shimamoto S.A., Starr P.A. Pallidal neuronal discharge in Parkinson's disease following intraputamenal fetal mesencephalic allograft. J. Neurol. Neurosurg. Psychiatry 2011, 82:266-271.
56. Rommelfanger K.S., Wichmann T. Extrastriatal dopaminergic circuits of the Basal Ganglia. Front. Neuroanat. 2010, 4:139.
57. Schiff M., Weinhold B., Grothe C., Hildebrandt H. NCAM and polysialyltransferase profiles match dopaminergic marker gene expression but polysialic acid is dispensable for development of the midbrain dopamine system. J. Neurochem. 2009, 110:1661-1673.
58. Sgambato-Faure V., Cenci M.A. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease. Prog. Neurobiol. 2012, 96:69-86.
59. Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol. Sci. 1998, 19:500-505.
60. Steigerwald F., Potter M., Herzog J., Pinsker M., Kopper F., Mehdorn H., Deuschl G., Volkmann J. Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state. J. Neurophysiol. 2008, 100:2515-2524.
61. Tai C.H., Yang Y.C., Pan M.K., Huang C.S., Kuo C.C. Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease. J. Clin. Invest. 2011, 121:3289-3305.
62. Talley E.M., Cribbs L.L., Lee J.H., Daud A., Perez-Reyes E., Bayliss D.A. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J. Neurosci. 1999, 19:1895-1911.
63. Timmer M., Grosskreutz J., Schlesinger F., Krampfl K., Wesemann M., Just L., Bufler J., Grothe C. Dopaminergic properties and function after grafting of attached neural precursor cultures. Neurobiol. Dis. 2006, 21:587-606.
64. Torres E.M., Dunnett S.B. Amphetamine induced rotation in the assessment of lesions and grafts in the unilateral rat model of Parkinson's disease. Eur. Neuropsychopharmacol. 2007, 17:206-214.
65. Trottenberg T., Kupsch A., Schneider G.-H., Brown P., Kühn A.A. Frequency-dependent distribution of local field potential activity within the subthalamic nucleus in Parkinson's disease. Exp. Neurol. 2007, 205:287-291.
66. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970, 24:485-493.
67. Villalba R.M., Smith Y. Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease. Front. Syst. Neurosci. 2011, 5:68.
68. Weinberger M., Mahant N., Hutchison W.D., Lozano A.M., Moro E., Hodaie M., Lang A.E., Dostrovsky J.O. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J. Neurophysiol. 2006, 96:3248-3256.
69. Wichmann T., DeLong M.R. Basal ganglia discharge abnormalities in Parkinson's disease. J. Neural Transm. Suppl. 2006, 21-5.
70. Wichmann T., Dostrovsky J.O. Pathological basal ganglia activity in movement disorders. Neuroscience 2011, 198:232-244.
71. Winkler C., Bentlage C., Cenci M.A., Nikkhah G., Bjorklund A. Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model. Neuroscience 2003, 118:1063-1077.
72. Wisden W., Laurie D.J., Monyer H., Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 1992, 12:1040-1062.
73. Yurek D.M., Fletcher-Turner A. Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons. Brain Res. 2002, 931:126-134.
74. Zhang T.A., Placzek A.N., Dani J.A. In vitro identification and electrophysiological characterization of dopamine neurons in the ventral tegmental area. Neuropharmacology 2010, 59:431-436.